Volume 148, Issue 1 | Breast Cancer Research and Treatment

Search all Breast Cancer Research and Treatment articles

Volume 148, Issue 1

November 2014

Filter by

Volume:

Sort by

Date published:

New to old Old to new

23 articles in this issue

Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review
Peter Andrew
Sabira Valiani
Shailendra Verma
Review 08 October 2014 Pages: 1 - 5
Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene
Suzanne Lam
Eliza Wiercinska
Aart G. Jochemsen
Preclinical Study 26 September 2014 Pages: 7 - 18
Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice
Muhammad Riaz
Buddy Setyono-Han
John W. M. Martens
Preclinical study 30 September 2014 Pages: 19 - 31
Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients
Mirjam E. Mast
Eline J. Vredeveld
John H. Maduro
Preclinical study Open access 01 October 2014 Pages: 33 - 39
Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome
Katherine Drews-Elger
Elizabeth Iorns
Marc E. Lippman
Preclinical Study 01 October 2014 Pages: 41 - 59
Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin
Honghai Hong
Ti Zhou
Guoquan Gao
Preclinical study 05 October 2014 Pages: 61 - 72
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series
Luigi Di Lauro
Patrizia Vici
Marcello Maugeri-Saccà
Clinical trial 20 September 2014 Pages: 73 - 80
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Andrea DeCensi
Matteo Puntoni
Michael N. Pollak
Clinical trial Open access 25 September 2014 Pages: 81 - 90
Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients
So-Youn Jung
Kyung Hwan Shin
Jungsil Ro
Clinical trial 25 September 2014 Pages: 91 - 98
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007
Kathy D. Miller
Sandra K. Althouse
Patricia S. Steeg
Clinical trial 26 September 2014 Pages: 99 - 106
A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy
Anton Buchner
Reiner Elsässer
Peter Bias
Clinical trial Open access 27 September 2014 Pages: 107 - 116
Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?
Monica Maria Yepes
Ada Pat Romilly
Stefan Glück
Clinical Trial 28 September 2014 Pages: 117 - 123
Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center
Mehra Golshan
Katya Losk
Craig Bunnell
Clinical trial 01 October 2014 Pages: 125 - 133
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
Tom Wei-Wu Chen
Ho-Min Chen
Yen-Shen Lu
Epidemiology 21 September 2014 Pages: 135 - 142
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies
Jessica Salmen
Julia Neugebauer
Brigitte Rack
Epidemiology 25 September 2014 Pages: 143 - 151
Diabetes, diabetes treatment and breast cancer prognosis
Juhua Luo
Beth Virnig
Karen Margolis
Epidemiology 27 September 2014 Pages: 153 - 162
Racial disparities in risk of second breast tumors after ductal carcinoma in situ
Ying Liu
Graham A. Colditz
Melody Goodman
Epidemiology 27 September 2014 Pages: 163 - 173
Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy
Yinzhi Lai
Juan P. Palazzo
Hushan Yang
Epidemiology 27 September 2014 Pages: 175 - 185
Mammography interval and breast cancer mortality in women over the age of 75
Michael S. Simon
Sylvia Wassertheil-Smoller
Lew H. Kuller
Epidemiology 25 September 2014 Pages: 187 - 195
Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer
Kazuhiro Araki
Ippei Fukada
Yoshinori Ito
Epidemiology 01 October 2014 Pages: 197 - 209
Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome
Michelle L. Baglia
Qiuyin Cai
Xiao-Ou Shu
Epidemiology 04 October 2014 Pages: 211 - 220
Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer
Rebecca Roylance
David Endesfelder
Charles Swanton
Brief Report 07 October 2014 Pages: 221 - 229
Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014
Alexandre Bricou
Emmanuel Barranger
Letter to the Editor 25 July 2014 Pages: 231 - 232